Inogen Announces First Quarter 2026 Financial Results
Inogen reported Q1 revenue of $85.1 million, up 3.4% year-over-year, exceeding its internal outlook as international demand offset softer U.S. sales. The company reiterated its full-year 2026 revenue guidance of $366 million to $373 million and authorized a $30 million share repurchase program. Product highlights included the U.S.
Key figures
- Revenue
- $85.1 million
- Guidance
- Q2 2026 revenue $94M-$97M; FY 2026 revenue $366M-$373M
- Revenue Yoy
- 3.4%
- Units sold
- 49000
- Gross margin
- 44.5%
- Net rental patients
- 47300
- Cash and equivalents
- 111500000
- Adjusted gross margin
- 44.7%
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.